Evoke Wealth’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,200
| Closed | -$129K | – | 1161 |
|
|
2022
Q3 | $129K | Buy |
3,200
+800
| +33% | +$32.3K | 0.01% | 380 |
|
|
2022
Q2 | $101K | Hold |
2,400
| – | – | ﹤0.01% | 414 |
|
|
2022
Q1 | $109K | Hold |
2,400
| – | – | ﹤0.01% | 421 |
|
|
2021
Q4 | $111K | Hold |
2,400
| – | – | ﹤0.01% | 429 |
|
|
2021
Q3 | $113K | Hold |
2,400
| – | – | ﹤0.01% | 412 |
|
|
2021
Q2 | $124K | Hold |
2,400
| – | – | ﹤0.01% | 408 |
|
|
2021
Q1 | $121K | Hold |
2,400
| – | – | 0.01% | 356 |
|
|
2020
Q4 | $125K | Hold |
2,400
| – | – | 0.01% | 281 |
|
|
2020
Q3 | $104K | Hold |
2,400
| – | – | 0.01% | 278 |
|
|
2020
Q2 | $103K | Buy |
2,400
+900
| +60% | +$38.6K | 0.01% | 269 |
|
|
2020
Q1 | $54.1K | Buy |
+1,500
| New | +$54.1K | 0.01% | 338 |
|
|
2019
Q4 | – | Sell |
-3,000
| Closed | -$107K | – | 1498 |
|
|
2019
Q3 | $107K | Buy |
+3,000
| New | +$107K | 0.01% | 356 |
|